Date: 15 July 2026
Time: 10:00 - 14:00
Location: RVC, 4 Royal College Street, NW1 0TU
The importance of outsourcing to Life Science R&D companies as they seek capital efficiency, speed to proof-of-concept data to unlock further investments and partnering has never been greater.
The emergence of China in particular as a major source of innovation and outsourcing options has created significant opportunity and competition in the R&D space, with nearly 50% of all Pharma R&D investment being deployed there in 2025 as reported in the recent EY Beyond Borders report.
This One Nucleus seminar will share and discuss insights on how companies can engage in these options in practice to achieve faster, better, cheaper value creation by leveraging external providers and partners in a compliant and effective way.
Agenda to follow soon.
If you have any questions about this seminar, please contact monalisa@onenucleus.com.
London BioScience Innovation Centre
2 Royal College Street
London
NW1 0NH
United Kingdom
Tel: +44 (0) 20 7691 1122